ArticlePloS one2020
Variation in the availability and cost of essential medicines for non-communicable diseases in Uganda: A descriptive time series analysis.
Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 25 citations in OpenAlex.
- Essential medicines out of reach: a cross-sectional study of community-level access in Eastern Uganda.BMC health services research · 2026Article
- Exploring factors affecting access to non-communicable disease medicines in low- and middle-income countries: a systematic review.BMJ public health · 2026Article
- Availability of essential medicines for non-communicable diseases: a scoping review of challenges and opportunities.BMJ global health · 2025Article
- The availability of essential medicines in public healthcare facilities in Afghanistan: navigating sociopolitical and geographical challenges.Health policy and planning · 2025Article
- Economic assessment of potential changes to essential medicines for diabetes in Uganda.PloS one · 2025Article
- Availability, price, and affordability of anti-hepatitis B virus drugs: a cross-sectional study in China.International journal of clinical pharmacy · 2024Article
- "These are just finishing our medicines": older persons' perceptions and experiences of access to healthcare in public and private health facilities in Uganda.BMC health services research · 2024Article
- Current out of pocket care costs among HIV and hypertension co-morbid patients in urban and peri-urban Uganda.PLOS global public health · 2024Article
- The role of the private sector in noncommunicable disease prevention and management in low- and middle-income countries: a series of systematic reviews and thematic syntheses.International journal of qualitative studies on health and well-being · 2023Review
- Design Research to Embed mHealth into a Community-Led Blood Pressure Management System in Uganda: Protocol for a Mixed Methods Study.JMIR research protocols · 2023Article
- Clinical Practices Following Train-The-Trainer Trauma Course Completion in Uganda: A Parallel-Convergent Mixed-Methods Study.World journal of surgery · 2023Article
- Review
- Bridging community and clinic through digital health: Community-based adaptation of a mobile phone-based heart failure program for remote communities in Uganda.BMC digital health · 2023Article
- Health supply chain system in Uganda: assessment of status and of performance of health facilities.Journal of pharmaceutical policy and practice · 2022Article
- Patient preferences for facility-based management of hypertension and diabetes in rural Uganda: a discrete choice experiment.BMJ open · 2022Article
- Health supply chain system in Uganda: current issues, structure, performance, and implications for systems strengthening.Journal of pharmaceutical policy and practice · 2022Review
- Impact of a COVID-19 National Lockdown on Integrated Care for Hypertension and HIV.Global heart · 2021Article
- Social Support for Self-Care: Patient Strategies for Managing Diabetes and Hypertension in Rural Uganda.Annals of global health · 2021Article
- Implementation, interrupted: Identifying and leveraging factors that sustain after a programme interruption.Global public healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAvailability of essential medicines for non-communicable diseases (NCDs) is poor in low- and middle-income countries. Availability and cost are conventionally assessed using cross-sectional data. However, these characteristics may vary over time.
methodsWe carried out a prospective, descriptive analysis of the availability and cost of essential medicines in 23 Ugandan health facilities over a five-week period. We surveyed facility pharmacies in-person up to five times, recording availability and cost of 19 essential medicines for NCDs and four essential medicines for communicable diseases.
resultsAvailability of medicines varied substantially over time, especially among public facilities. Among private-for-profit facilities, the cost of the same medicine varied from week to week. Private-not-for-profit facilities experienced less dramatic fluctuations in price.
conclusionsWe conclude that there is a need for standardized, continuous monitoring to better characterize the availability and cost of essential medicines, understand demand for these medicines, and reduce uncertainty for patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.